Zimmer Biomet Holdings's quarterly market cap
declined
from Mar. 2024 ($27,148 Mil) to Jun. 2024 ($22,238 Mil) and
declined
from Jun. 2024 ($22,238 Mil) to Sep. 2024 ($21,547 Mil).
Zimmer Biomet Holdings's annual market cap
increased
from Dec. 2021 ($25,758 Mil) to Dec. 2022 ($26,648 Mil) but then
declined
from Dec. 2022 ($26,648 Mil) to Dec. 2023 ($25,022 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zimmer Biomet Holdings's Enterprise Value for Today is $27,273 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zimmer Biomet Holdings's Market Cap
For the Medical Devices subindustry, Zimmer Biomet Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Market Cap falls into.
Zimmer Biomet Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zimmer Biomet Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (NYSE:ZBH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zimmer Biomet Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZBH has been successfully added to your 